Cargando…
MerTK, a risk factor for NASH fibrosis
Autores principales: | Wang, Xiaobo, Cai, Bishuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655196/ https://www.ncbi.nlm.nih.gov/pubmed/33125345 http://dx.doi.org/10.18632/aging.104210 |
Ejemplares similares
-
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017) -
Harnessing MerTK agonism for targeted therapeutics
por: Kedage, Vivekananda, et al.
Publicado: (2019) -
The Synthesis and Initial Evaluation of MerTK Targeted PET Agents
por: Wang, Li, et al.
Publicado: (2022) -
MerTK is required for apoptotic cell–induced T cell tolerance
por: Wallet, Mark A., et al.
Publicado: (2008) -
MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015)